p.Val804Met, the most frequent pathogenic mutation in RET, confers a very low lifetime risk of medullary thyroid cancer.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620674
Title:
p.Val804Met, the most frequent pathogenic mutation in RET, confers a very low lifetime risk of medullary thyroid cancer.
Authors:
Loveday, C.; Josephs, K.; Chubb, D.; Gunning, A.; Izatt, L.; Tischkovitz, M.; Ellard, Sian ( 0000-0002-7620-5526 ) ; Turnbull, C.
Abstract:
To date, penetrance figures for medullary thyroid cancer (MTC) for variants in RET have been estimated from families ascertained on account of presence of MTC.
Citation:
p.Val804Met, the most frequent pathogenic mutation in RET, confers a very low lifetime risk of medullary thyroid cancer. 2018 J. Clin. Endocrinol. Metab.
Publisher:
Endocrine Society
Journal:
The Journal of clinical endocrinology and metabolism
Issue Date:
23-Mar-2018
URI:
http://hdl.handle.net/11287/620674
DOI:
10.1210/jc.2017-02529
PubMed ID:
29590403
Additional Links:
https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2017-02529
Type:
Journal Article
Language:
en
ISSN:
1945-7197
Appears in Collections:
Molecular Genetics; 2018 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorLoveday, C.en
dc.contributor.authorJosephs, K.en
dc.contributor.authorChubb, D.en
dc.contributor.authorGunning, A.en
dc.contributor.authorIzatt, L.en
dc.contributor.authorTischkovitz, M.en
dc.contributor.authorEllard, Sianen
dc.contributor.authorTurnbull, C.en
dc.date.accessioned2018-05-03T14:24:55Z-
dc.date.available2018-05-03T14:24:55Z-
dc.date.issued2018-03-23-
dc.identifier.citationp.Val804Met, the most frequent pathogenic mutation in RET, confers a very low lifetime risk of medullary thyroid cancer. 2018 J. Clin. Endocrinol. Metab.en
dc.identifier.issn1945-7197-
dc.identifier.pmid29590403-
dc.identifier.doi10.1210/jc.2017-02529-
dc.identifier.urihttp://hdl.handle.net/11287/620674-
dc.description.abstractTo date, penetrance figures for medullary thyroid cancer (MTC) for variants in RET have been estimated from families ascertained on account of presence of MTC.en
dc.language.isoenen
dc.publisherEndocrine Societyen
dc.relation.urlhttps://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2017-02529en
dc.rightsArchived with thanks to The Journal of clinical endocrinology and metabolismen
dc.subjectWessex Classification Subject Headings::Oncology. Pathology.::Geneticsen
dc.titlep.Val804Met, the most frequent pathogenic mutation in RET, confers a very low lifetime risk of medullary thyroid cancer.en
dc.typeJournal Articleen
dc.identifier.journalThe Journal of clinical endocrinology and metabolismen
dc.type.versionIn press (epub ahead of print)en

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.